Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes

Completed · Not applicable

Conditions studied: Primary Open Angle Glaucoma, Pseudoexfoliative Glaucoma, Pigmentary Glaucoma

In brief

This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.

Key facts

Study ID

NCT02023242

Run by

Ivantis, Inc.

People needed

152

Starts

2012-10-01

Expected to finish

2018-01-01

Last updated by the study team

2019-12-10

Who can join

Age: 45 and older, up to 84. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A diagnosis of primary open angle glaucoma (POAG), Pseudoexfoliative (PXG) glaucoma, or Pigmentary glaucoma (PG)
• A phakic lens with BCVA of 20/30 or better

You may not qualify if…

• Forms of primary or secondary glaucoma not listed above
• Prior glaucoma surgery in the study eye

Where it is running

• Contact Richard Hope at Ivantis — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.